Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Change in Account Payables (2023 - 2025)

Historic Change in Account Payables for Chemours (CC) over the last 5 years, with Q3 2025 value amounting to $8.0 million.

  • Chemours' Change in Account Payables fell 9101.12% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year decrease of 9364.16%. This contributed to the annual value of $4.0 million for FY2024, which is 10540.54% up from last year.
  • As of Q3 2025, Chemours' Change in Account Payables stood at $8.0 million, which was down 9101.12% from $18.0 million recorded in Q2 2025.
  • In the past 5 years, Chemours' Change in Account Payables ranged from a high of $259.0 million in Q4 2023 and a low of -$165.0 million during Q2 2023
  • For the 3-year period, Chemours' Change in Account Payables averaged around -$13.5 million, with its median value being -$19.0 million (2024).
  • In the last 5 years, Chemours' Change in Account Payables tumbled by 25454.55% in 2024 and then soared by 19473.68% in 2025.
  • Chemours' Change in Account Payables (Quarter) stood at $259.0 million in 2023, then plummeted by 65.25% to $90.0 million in 2024, then crashed by 91.11% to $8.0 million in 2025.
  • Its Change in Account Payables was $8.0 million in Q3 2025, compared to $18.0 million in Q2 2025 and -$105.0 million in Q1 2025.